National Security Commission on Emerging Biotechnology

What National Security Commission on Emerging Biotechnology does

The National Security Commission on Emerging Biotechnology (NSCEB) is an independent legislative branch advisory entity established by Section 1091 of the FY22 National Defense Authorization Act (Public Law 117-81) and operational since 2022. It is composed of 12 commissioners appointed by bipartisan, bicameral Congressional leadership, including the chairs and ranking members of the House and Senate Armed Services Committees, and external experts from industry and academia such as Dr. Eric Schmidt, Dr. Angela Belcher, and Dr. Dov Zakheim. The Commission's statutory mandate is to conduct a thorough review of how advances in emerging biotechnology and related technologies will shape current and future activities of the Department of Defense, and to deliver policy recommendations to Congress and the federal government.

NSCEB's core deliverables are its December 2023 interim report, its April 2025 final report containing 49 policy recommendations, an online Recommendation Tracker monitoring legislative and executive branch progress, three post-report Discussion Papers (Future of Science, U.S.-China Biotechnology Competition, Biotechnology Regulation), the Biotech Across America Roadshow (22 states and 400+ organizations engaged as of June 2026), and the Bioliteracy In Action initiative. Associated legislative outputs include the America's Living Library Act of 2026 and the Web of Biological Data Act of 2026. By June 2026, 26 NSCEB-derived provisions have been signed into law, 36 recommendations have seen bipartisan legislative action, and 9 are reflected in White House executive actions.

The Commission is funded entirely through Congressional appropriations and receives administrative services and support from the Secretary of Defense and the Administrator of General Services. It charges no fees, sells no products, and operates on a government appropriation model with no commercial revenue mechanics. It is time-limited, with statutory authority scheduled to sunset approximately end of 2026 (18 months after the April 2025 final report submission), though its policy outputs continue through the FY27 NDAA cycle and via the House BIOtech Caucus launched in June 2025.

Name

National Security Commission on Emerging Biotechnology

Legal name

National Security Commission on Emerging Biotechnology

Website

https://biotech.senate.gov

Company type

Public

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

The National Security Commission on Emerging Biotechnology (NSCEB) is a U.S. legislative branch advisory commission, established in 2022 by the FY22 NDAA, that produces policy research and 49 recommendations on biotechnology and national security for Congress, the Department of Defense, and the federal government.

Ownership category

akta.pro rank

Product category

Government Biotechnology Policy Advisory Services

NAICS

Scientific Research and Development Services (5417)

akta.pro primary industry

Science, Technology & Innovation Administration (National R&D Policy) (BPAIAAAK)

akta.pro secondary industry

Defense R&D, Test, Evaluation & Innovation (BPAIAHAC)

Keywords

• Biotechnology policy research
• National security advisory
• Legislative commission reports
• Biodefense policy analysis
• Government biotechnology recommendations

Headquarters

HQ city

Arlington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others

Revenue model

1. Government Appropriation: The Commission is a legislative branch advisory entity funded through Congressional appropriations as established by FY22 NDAA Section 1091. The Commission receives administrative services, funds, staff, facilities, and other support services from the Secretary of Defense.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

The NSCEB conducts a thorough review of how advancements in emerging biotechnology and related technologies will shape current and future U.S. national defense activities. It produces comprehensive policy reports (interim December 2023 and final April 2025 with 49 recommendations), tracks legislative and executive branch implementation via an online Recommendation Tracker, and engages the biotech ecosystem through the Biotech Across America Roadshow and Bioliteracy Initiative.

Product overview

The National Security Commission on Emerging Biotechnology is a time-limited legislative branch advisory entity (statutory authority sunsets December 2026) that does not offer a commercial product in the traditional sense. The Commission's core deliverables include its comprehensive Final Report (April 2025) with 49 policy recommendations, the online Recommendation Tracker monitoring legislative progress, the Biotech Across America Roadshow initiative visiting states to engage with biotech ecosystems, and the Bioliteracy In Action program highlighting educational organizations. The Commission also produces Discussion Papers on critical topics including U.S.-China biotechnology competition, the future of science, and biotechnology regulation. Key legislative proposals associated with the Commission include the America's Living Library Act and the Web of Biological Data Act.

Differentiator

Problem solved

Functional benefit

Brands

• Biotech Across America Roadshow: NSCEB's initiative to visit companies, academic institutions, industry alliances, workforce development programs, and policy initiatives across America to highlight biotechnology and engage on key findings from the commission's report.
• Bioliteracy

Products and services

• NSCEB Final Report and Action Plan Comprehensive policy report delivering an Action Plan for U.S. biotechnology leadership, including 49 policy recommendations for Congress and the federal government to advance and secure biotechnology for national security. Submitted to congressional defense committees and the President.
• NSCEB Recommendation Tracker Online tracker monitoring legislative and executive branch progress on the 49 NSCEB policy recommendations, showing which provisions have been signed into law, introduced as bills, or included in executive actions.
• Biotech Across America Roadshow Commission initiative traveling across the United States to highlight biotechnology companies, academic institutions, industry alliances, workforce development programs, and policy initiatives driving the biotechnology industry. As of June 2026, has visited 22 states and engaged 400+ organizations.
• Bioliteracy In Action Initiative showcasing organizations across America driving bioliteracy efforts and expanding access to biology education, tools, and resources for the public, students, and workers.
• NSCEB Discussion Papers Three discussion papers published after the April 2025 report: The Future of Science, The Future of U.S.-China Biotechnology Competition, and The Future of Biotechnology Regulation.
• NSCEB Interim Report (December 2023) NSCEB's first public report published after its first year of work, presenting early ideas on biotechnology and national security that were refined in the April 2025 comprehensive report.
• NSCEB 2025 Year in Review Report Report documenting NSCEB's activities in 2025, including legislative progress, roadshow events across 18 states, and the Commission's impact on bipartisan biotechnology policy.

Quantifiable outcome

• 21 provisions signed into law reflecting NSCEB recommendations
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

47 partnerships are on record, tiered core and minor.

• Blackrock NeurotechcoreStrategic or Co-development Partner · 13 November 2025NSCEB visited Blackrock Neurotech, a company revolutionizing brain-computer interface technology, to learn about cutting-edge innovation critical to national security.
• RecursioncoreStrategic or Co-development Partner · 13 November 2025NSCEB visited Recursion, a pioneering AI drug discovery company, to understand commercialization and workforce development critical to national security.
• CleanJoulecoreStrategic or Co-development Partner · 13 November 2025NSCEB visited CleanJoule to learn about biomanufactured high-performance aviation fuel. The company works with U.S. Department of Defense and other federal agencies on technological advancements with significant national security impact.
• BioHivecoreStrategic or Co-development Partner · 11 November 2025BioHive hosted an NSCEB reception in Salt Lake City with over 20 organizations from industry, academia, and nonprofit sector to discuss how biotech contributes to U.S. national security and economic resilience.
• Greater Houston PartnershipcoreStrategic or Co-development PartnerHosted many of the Commission's meetings in conjunction with University of Houston's Technology Bridge innovation hub and Texas Medical Center.
• Texas Medical CentercoreStrategic or Co-development PartnerNSCEB toured TMC's biomanufacturing incubator lab and mobile lab bringing hands-on biotech experience to local high school students through BioPath program.
• University of HoustoncoreStrategic or Co-development PartnerNSCEB discussed the region's biotech outlook and toured the University's Technology Bridge innovation hub.
• CemvitacoreStrategic or Co-development PartnerNSCEB toured Cemvita's industrial biomanufacturing facility, learning about nature-inspired solutions for sustainable and scalable industrial biotech.
• San Jacinto Community CollegecoreStrategic or Co-development PartnerNSCEB attended ribbon cutting ceremony for the Center for Biotechnology, enabling expansion of regional workforce trained in cutting-edge bioeconomy technology and skills.
• ATCCcoreStrategic or Co-development PartnerNSCEB partnered with ATCC, a non-profit biological resources and standards organization, to explore paths to building a resilient national biotech industry. Event brought together biotech industry leaders, Virginia state lawmakers, and national biotech champions.
• Baltimore Underground Science SpaceminorStrategic or Co-development PartnerNon-profit makerspace laboratory in Baltimore, MD offering classes, lab access, and biology projects supporting community research and education as part of Bioliteracy Initiative.
• BEAM CircularminorStrategic or Co-development PartnerHub for circular bioeconomy innovation and workforce development in Modesto, CA with a Bioeconomy Workforce Development Fund supporting K-12 STEM and CTE programs.
• BioBuilderminorStrategic or Co-development PartnerBioBuilder's programs provide high school students early exposure to bioscience through lab and internship opportunities in Boston, MA.
• NIIMBLcoreStrategic or Co-development PartnerNational Institute for Innovation in Manufacturing Biopharmaceuticals - public-private partnership showcasing how government and industry partnerships drive excellence in innovation and workforce development.
• Lawrence Berkeley National LaboratorycoreStrategic or Co-development PartnerNSCEB toured ABPDU, Agile BioFoundry, and Joint BioEnergy Institute facilities driving innovation in biomanufacturing.
• Bakar LabsminorStrategic or Co-development PartnerIncubator for life science start-ups where NSCEB joined roundtable discussion with biotech investors.
• Georgia Bioscience Training CentercoreStrategic or Co-development PartnerPublic-private partnership facility driving biomanufacturing training opportunities in Covington, GA.
• NSF Engineering Research Center for Cell Manufacturing (CMaT)coreStrategic or Co-development PartnerNSCEB visited NSF facility at Georgia Tech meeting students from ARCS Foundation and iGEM program.
• ManuscoreStrategic or Co-development PartnerNSCEB toured Manus' biomanufacturing facility in Augusta, one of the largest biomanufacturing sites in the U.S., formerly the NutraSweet manufacturing facility.
• Carnegie Mellon UniversitycoreStrategic or Co-development PartnerNSCEB toured CMU's Biological and Chemical Innovation Lab at AI Science Foundry, including autonomous cloud laboratory where AI, robotics, and automation unlock new discoveries.
• BioForgecoreStrategic or Co-development PartnerState-of-the-art biomanufacturing center built by University of Pittsburgh and ElevateBio at a former steel plant. 185,000 square foot facility expected to create nearly 200 new biomanufacturing jobs.
• Princeton UniversitycoreStrategic or Co-development PartnerNSCEB joined Representative Herb Conaway at Princeton's Omenn-Darling Bioengineering Institute to discuss AIxBio convergence.
• Amicus TherapeuticsminorStrategic or Co-development PartnerNew Jersey-based biotechnology company focused on therapies for rare diseases, co-hosting NSCEB event.
• BioNJcoreStrategic or Co-development PartnerStatewide non-profit association acting as advocate to spur economic collaboration in New Jersey's biotech ecosystem.
• NCBiotechcoreStrategic or Co-development PartnerNorth Carolina Biotechnology Center - discussion on state of NC biotechnology industry and leadership in biopharma manufacturing.
• NovonesiscoreStrategic or Co-development PartnerNSCEB toured Novonesis enzyme manufacturing facility in Franklinton, NC to discuss agricultural biotechnology innovations serving national security.
• iFAB Tech HubcoreStrategic or Co-development PartnerIllinois Fermentation and Agriculture Biomanufacturing Tech Hub - consortium connecting industry leaders with innovative start-ups and local resources.
• ADMminorStrategic or Co-development PartnerNSCEB toured ADM Decatur plant as part of exploring regional biomanufacturing capacity.
• University of Illinois Urbana-ChampaigncoreStrategic or Co-development PartnerHost of NSCEB events with industry leaders, academic stakeholders, and local government officials discussing national impact of regional biotech innovation hub.
• BioTCcoreStrategic or Co-development PartnerOklahoma's dedicated biomanufacturing training center delivering hands-on learning experiences and workforce development for students seeking biotech careers.
• Innovation HallcoreStrategic or Co-development PartnerOklahoma City venue for NSCEB meetings with local biotech leaders, academics, and officials discussing policy levers for workforce development and biomanufacturing scaling.
• New Orleans BioInnovation CentercoreStrategic or Co-development PartnerNOBIC hosted Commissioner Titus for presentation on New Orleans biotech ecosystem and discussions with local biotech company founders.
• LSU Health Sciences CenterminorStrategic or Co-development PartnerNSCEB toured facility where cutting-edge training programs are making New Orleans a hub for advanced health sciences talent development.
• Xavier University of LouisianaminorStrategic or Co-development PartnerNSCEB toured XULA's soon-to-open Ochsner College of Medicine showcasing higher education partnering with private sector for talent development.
• NIIMBLcoreStrategic or Co-development PartnerNational Institute for Innovation in Manufacturing Biopharmaceuticals - NSCEB toured state-of-the-art facility and participated in roundtable on public-private partnership model.
• Lawrence Berkeley National LabcoreStrategic or Co-development PartnerNSCEB commissioners engaged with Bay Area biotech start-ups and visited ABPDU, Agile BioFoundry, and Joint BioEnergy Institute facilities.
• UC MercedcoreStrategic or Co-development PartnerNSCEB met with local industry and academic leaders to discuss biotechnology innovation, agriculture, and national security role of Central Valley.
• BEAM CircularminorStrategic or Co-development PartnerNonprofit supporting California's circular bioeconomy in Modesto, showcasing how bioeconomy innovation supports farmers and regional economy.
• Caribou BioFuelsminorStrategic or Co-development PartnerNSCEB toured facility making cutting-edge tool to convert biomass into fuel, demonstrating biotech solutions for farmers.
• VOLT InstituteminorStrategic or Co-development PartnerHands-on manufacturing training center in Modesto helping build workforce foundation for emerging biotechnologies.
• Element BiosciencescoreStrategic or Co-development PartnerNSCEB visited to learn about advanced sequencing technologies and genomic data capabilities.
• San Diego Zoo Wildlife AlliancecoreStrategic or Co-development PartnerNSCEB met with leaders to learn about conservation efforts through Safari Park and Beckman Center, including Frozen Zoo and Conservation Technology Lab.
• IlluminacoreStrategic or Co-development PartnerSan Diego biotech ecosystem participant exploring advanced sequencing technologies.
• Scripps Institute for OceanographyminorStrategic or Co-development PartnerSan Diego participant exploring biotechnology applications in ocean science.
• East Tennessee State UniversitycoreStrategic or Co-development PartnerNSCEB met with academic and industry leadership to learn about thriving workforce development programs and biotech ecosystem.
• Niswonger FoundationminorStrategic or Co-development PartnerNSCEB toured Niswonger Foundation-powered BioBuilder Learning Lab engaging with local high school students.
• LimulusminorStrategic or Co-development PartnerLocal biotech industry leader in Johnson City/Kingsport TN area toured as part of regional innovation showcase.

Scale indicators11 records

Recent moves8 records

Expansion highlights5 records

Emerging players

• Information Technology and Innovation Foundation (ITIF): Public policy think tank focused on technology, innovation, and global competitiveness — including biotech competitiveness versus China. Comparable as a policy research organization publishing actionable recommendations for Congress and the executive branch.
• Federation of American Scientists (FAS): Nonprofit policy organization providing science and technology analysis to policymakers, with active work on biosecurity and emerging biotech. Comparable as a science-policy stakeholder publishing reports for Congressional audiences but operates as a nonprofit rather than a federal commission.
• Bipartisan Policy Center (BPC): Think tank producing bipartisan policy analysis across health, national security, and economic policy domains. Comparable as a cross-ideological convening body producing policy recommendations, though as a nonprofit rather than a federally chartered commission.

Others

• Council on Foreign Relations (CFR): Nonpartisan think tank publishing analysis on U.S. foreign policy, including biotechnology, biosecurity, and US-China strategic competition. Comparable as a policy research organization informing Congressional debate on national security topics adjacent to NSCEB's mandate.
• American Association for the Advancement of Science (AAAS): International nonprofit producing science policy analysis, R&D budget assessments, and Congressional briefings. Comparable as a science-policy stakeholder informing federal science funding and biotech regulation, though not a federal commission itself.
• National Academies of Sciences, Engineering, and Medicine: Congressionally chartered advisory body producing authoritative reports on science, engineering, and medicine, including biotechnology and biosecurity. Comparable as a federally affiliated science-policy advisory institution, though broader in scope and longer-lived than NSCEB.

Broad incumbents

• National Science Board (NSB): Independent federal body that oversees the National Science Foundation and advises Congress on U.S. science and engineering policy. Comparable as a federally chartered science-policy advisory entity, though focused on NSF and broader S&T rather than biotech/national security.
• President's Council of Advisors on Science and Technology (PCAST): Executive-branch advisory body advising the President on science, technology, and innovation policy. Comparable in providing high-level federal S&T policy advice but operates within the executive branch rather than the legislative branch and covers all of S&T rather than biotech specifically.

Direct peers

• Cyberspace Solarium Commission: Congressionally chartered legislative-branch commission that produced a comprehensive cybersecurity policy report with concrete legislative recommendations. Highly comparable in structure, mission (emerging tech + national security), and Congressional engagement model to NSCEB.
• National Security Commission on Artificial Intelligence (NSCAI): Final report (2021) advising Congress and the President on AI and national security. Closely analogous to NSCEB in legislative-branch advisory commission structure, statutory mandate, commissioner composition, and report-driven legislative impact model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/biotech_gov
• LinkedInlinkedin.com/company/national-security-commission-on-emerging-biotechnology-nsceb

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Security Commission on Emerging Biotechnology